Postoperative Donor Specific Anti-HLA Antibodies in Lung Transplantation: Risk Factors and Impact on Mid-Term Patient and Graft Outcomes

被引：0
|
作者：
Ius, F. [1 ]
Sommer, W. [1 ]
Tudorache, I. [1 ]
Kuehn, C. [1 ]
Avsar, M. [1 ]
Siemeni, T. [1 ]
Salman, J. [1 ]
Hallensleben, M. [2 ]
Greer, M. [3 ]
Gottlieb, J. [3 ]
Haverich, A. [1 ]
Warnecke, G. [1 ]
机构：
[1] Hannover Med Sch, Dept Cardiothorac Transplant & Vasc Surg, Hannover, Germany
[2] Hannover Med Sch, Dept Transfus Med, Hannover, Germany
[3] Hannover Med Sch, Dept Resp Med, Hannover, Germany
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2014年 / 33卷 / 04期
关键词：
D O I：
10.1016/j.healun.2014.01.426
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
419
引用
收藏
页码：S159 / S159
页数：1
相关论文
共 50 条
  • [1] Risk Factors for the Development of Early Anti-HLA Donor Specific Antibodies After Lung Transplantation: The Role of Primary Graft Dysfunction
    Salman, J.
    Aburahma, K.
    Franz, M.
    Schwerk, N.
    Greer, M.
    Falk, C.
    Welte, T.
    Haverich, A.
    Kuehn, C.
    Warnecke, G.
    Ius, F.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2022, 41 (04): : S259 - S259
  • [2] Impact on mid-term kidney graft outcomes of pretransplant anti-HLA antibodies detected by solid-phase assays: Do donor-specific antibodies tell the whole story?
    Malheiro, Jorge
    Tafulo, Sandra
    Dias, Leonidio
    Martins, La Salete
    Fonseca, Isabel
    Beirao, Idalina
    Castro-Henriques, Antonio
    Cabrita, Antonio
    HUMAN IMMUNOLOGY, 2017, 78 (09) : 526 - 533
  • [3] Early Donor-Specific Anti-HLA Antibodies in Lung Transplantation: Impact on Survival and Risk of Chronic Lung Allograft Dysfunction
    Le Pavec, J.
    Lamrani, L.
    Suberbielle, C.
    Thabut, G.
    Fabre, D.
    Mussot, S.
    Dartevelle, P.
    Mercier, O.
    Fadel, E.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2015, 34 (04): : S252 - S252
  • [4] Non-Donor-Specific Anti-HLA Antibodies Have an Adverse Impact in Kidney Graft Outcomes
    Malheiro, J.
    Tafulo, S.
    Dias, L.
    Martins, L.
    Beirao, I.
    Castro-Henriques, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 539 - 539
  • [5] DONOR SPECIFIC ANTI-HLA IGA ANTIBODIES AND GRAFT SURVIVAL AFTER KIDNEY TRANSPLANTATION
    Arnold, Marie-Luise
    Bach, Christian
    Heinemann, Falko M.
    Dick, Andrea
    Spriewald, Bernd M.
    HLA, 2018, 91 (05) : 358 - 358
  • [6] IMPACT OF DONOR-SPECIFIC ANTI-HLA ANTIBODIES ON GRAFT FAILURE AFTER UNRELATED DONOR HEMATOPOIETIC CELL TRANSPLANTATION
    Lima, Alberto C.
    Getz, Joselito
    Dornelles, Luciana N.
    Amaral, Geovana B.
    Loth, Gisele
    Funke, Vaneuza A.
    Nabhan, Samir K.
    Pereira, Noemi F.
    Bonfim, Carmem
    Pasquini, Ricardo
    HUMAN IMMUNOLOGY, 2020, 81 : 30 - 30
  • [7] Donor-Specific Anti-HLA Antibodies in Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide: Risk of Graft Failure, Poor Graft Function, and Impact on Outcomes
    Bramanti, Stefania
    Calafiore, Valeria
    Longhi, Elena
    Mariotti, Jacopo
    Crespiatico, Loretta
    Sarina, Barbara
    De Philippis, Chiara
    Nocco, Angela
    Santoro, Armando
    Castagna, Luca
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (07) : 1395 - 1406
  • [8] Donor specific anti-hla antibodies (DSA) in haploidentical stem cell transplantation with post transplant cyclophosphamide: Risk of graft failure, poor graft function and impact on outcomes
    Bramanti, Stefania
    Calafiore, Valeria
    Longhi, Elena
    Mariotti, Jacopo
    Crespiatico, Loretta
    Sarina, Barbara
    Nocco, Angela
    De Philippis, Chiara
    Santoro, Armando
    Castagna, Luca
    BONE MARROW TRANSPLANTATION, 2019, 54 : 562 - 563
  • [9] The impact of donor specific anti-HLA antibodies on the outcome of allogeneic stem cell transplantation
    Kekik, C.
    Yonal-Hindilerden, I.
    Savran-Oguz, F.
    Usta, S.
    Temurhan, S.
    Batu-Demir, D.
    Kalayoglu-Besisik, S.
    Aktan, M.
    Sargin, D.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S166 - S166
  • [10] De novo donor-specific anti-HLA antibodies are a risk factor for graft loss in DCD liver transplantation
    Andacoglu, Oya
    Ellis, Thomas
    D'Alessandro, Anthony M.
    Foley, David
    Powell, Amy
    Leverson, Glen E.
    Lucey, Michael R.
    Musat, Alexandru I.
    HEPATOLOGY, 2013, 58 : 211A - 211A
12345